Supplier to physician dispensing doubles capacity at new larger facility

Joseph DiPiro, PharmD, FCCP, FAAAS, editor of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast, discussed key themes in the forecast that will impact health-system pharmacy in 2025.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.

The patient’s symptoms gradually resolved after discontinuing fezolinetant therapy.